Sep 22, 2026 6 0
Uploaded by Jordan Avery
Favorite
Share
More Options
12
Preclinical Evaluation of AHT-102, a CLDN18.2 × CD3 Bispecific Antibody - Pharmacokinetics, Anti-Tumor Efficacy, Tissue Distribution, and Safety Profile_Page 1

Open in WPS to view all 12 pages